NCT00018603View on ClinicalTrials.gov

Guanfacine for the Treatment of Post Traumatic Stress Disorder (PTSD)

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1999

Study Completion Date

October 31, 2002

Conditions
Post-Traumatic Stress Disorder
Interventions
DRUG

guanfacine

Trial Locations (1)

06516

VA Connecticut Healthcare System, West Haven

All Listed Sponsors
lead

US Department of Veterans Affairs

FED

NCT00018603 - Guanfacine for the Treatment of Post Traumatic Stress Disorder (PTSD) | Biotech Hunter | Biotech Hunter